Skip to main content

Table 2 Primary and secondary outcomes

From: Systolic blood pressure values might further risk-stratify the adverse outcomes of LVH in older patients with chronic kidney disease

 

SBP < 130 and LVH

SBP ≥130 and LVH

SBP < 130 and no LVH

SBP ≥130 and no LVH

P value

CVE, %

7 (21.2)

25 (37.9)

7 (10.3)

8 (10.5)

<0.0001

Death, %

3 (9)

5 (7.58)

4 (5.9)

1 (1.32)

0.25

Changes in GFR during follow up (cc/min/BSA)

-5.27 ± 9.48

-3.57 ± 12.1

-5 ± 15.4

-7.7 ± 13.2

0.31

ESRD, %

1 (3)

4 (6)

0

2 (2.63)

0.22

  1. CVE cardiovascular events, BSA body surface area, ESRD end stage renal disease, GFR glomerular filtration rate